The LATEST RESTRUCTURING Now, TLN is trying to restructure the company. My guess is they are trying to sell the company to the highest bidders. The Phase 11 Shigamab is completed. However we shareholders still do not know the result of the testing. May be it is worthy to market the drug or may be not. We have absolutely no clue. However the financial situation of tln is good. According to the latest information, the cash position is worth about 28 cents per share. The trading price at this moment is about 11 cents. All I am hoping is , my fellow shareholder, hold on to your shares. I hope TLN could be sold @ mote than 50 cents per share. I need your comments, fellown shareholders.